# Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn Infants

> **NCT00516360** · PHASE4 · UNKNOWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 150 (estimated)

## Conditions studied

- Catheterization

## Interventions

- **DEVICE:** 3.15% chlorhexidine as daily antiseptic on needleless access port

## Key facts

- **NCT ID:** NCT00516360
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-07
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2008-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00516360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00516360, "Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn Infants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00516360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*